Literature DB >> 6692306

The grade and pathologic stage of bladder cancer.

W H Kern.   

Abstract

One hundred fourteen cases of bladder cancers treated during a 3-year period by cystectomy were uniformly reclassified, graded, and pathologically staged. One hundred thirty-one cases treated during the same period by transurethral or segmental resection were similarly reclassified and checked for muscle invasion. Sixty-one percent of the cystectomy cases were nonpapillary and 69% of the conservatively treated cases were papillary transitional cell carcinomas. In the pathologically staged cystectomy group, all poorly differentiated (grade III and IV) carcinomas were invasive. Nonpapillary tumors were more aggressive and 79% of the high grade tumors in these categories extended into the outer portions of the muscularis or into perivesical tissues. Muscle invasion could also be demonstrated in 74% of the 23 high-grade nonpapillary carcinomas in the conservatively treated cases. Lymph node and pelvic wall metastases were found in 17% of the cystectomies and were present only in tumor grades III and IV and a pathologic stage of P-3B or higher. None of the well differentiated (grade I) papillary carcinomas were invasive and invasion was superficial in most moderately differentiated (grade II) papillary tumors. The findings confirm that pathologic classification and grading of bladder carcinomas correlate closely with the stage of the disease.

Entities:  

Mesh:

Year:  1984        PMID: 6692306     DOI: 10.1002/1097-0142(19840301)53:5<1185::aid-cncr2820530526>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.

Authors:  R Moll; T Achtstätter; E Becht; J Balcarova-Ständer; M Ittensohn; W W Franke
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

2.  Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.

Authors:  H E Schaafsma; F C Ramaekers; G N van Muijen; E B Lane; I M Leigh; H Robben; A Huijsmans; E C Ooms; D J Ruiter
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

3.  Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.

Authors:  I A Korneyev; N N Mamaev; V V Kozlov; M G Rybakova; S H al-Shukri
Journal:  Mol Pathol       Date:  2000-06

4.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.

Authors:  C Cordon-Cardo; D D Wartinger; M R Melamed; W Fair; Y Fradet
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  Collagen IV staining pattern in bladder carcinomas: relationship to prognosis.

Authors:  N Daher; H Abourachid; N Bove; J Petit; P Burtin
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

7.  The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology.

Authors:  Simone de Brot; Brian D Robinson; Tim Scase; Llorenç Grau-Roma; Eleanor Wilkinson; Stephen A Boorjian; David Gardner; Nigel P Mongan
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.